Quantum Biopharma (QNTM) Research & Development (2020 - 2026)
Quantum Biopharma's (QNTM) quarterly Research & Development came in at $626092.0 in Q1 2026, down 62.02% year-on-year from $1.6 million in Q1 2025, and up 789.28% quarter-over-quarter from $70404.0 in Q4 2025.
Quantum Biopharma (QNTM) Research & Development (2020 - 2026) Analysis & Trends
Quantum Biopharma has disclosed Research & Development across 7 years of filings, most recently posting $626092.0 for Q1 2026.
- Research & Development for Q1 2026 came in at $626092.0, down 62.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 49.56% YoY), and the FY2025 annual result was $2.8 million, down 54.58% from the prior year.
- Research & Development came in at $626092.0 for Q1 2026 at Quantum Biopharma, up from $70404.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.3 million in Q1 2023 to a low of $32985.0 in Q3 2023.
- The 5-year median for Research & Development is $587644.5 (2025), against an average of $719517.2.
- Peak annual rise in Research & Development reached 2158.0% in 2024, while the deepest fall reached 93.07% in 2024.
- Quantum Biopharma's Research & Development stood at $937052.0 in 2022, then plunged by 96.48% to $32985.0 in 2023, then surged by 385.86% to $160260.0 in 2024, then slumped by 56.07% to $70404.0 in 2025, then surged by 789.28% to $626092.0 in 2026.
- The last three Research & Development figures came in at $626092.0 (Q1 2026), $70404.0 (Q4 2025), and $495223.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 626,092.00 |
| Dec 31, 2025 | 70,404.00 |
| Sep 30, 2025 | 495,223.00 |
| Jun 30, 2025 | 549,197.00 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 160,260.00 |
| Sep 30, 2024 | 744,802.00 |
| Jun 30, 2024 | 897,986.00 |
| Mar 31, 2024 | 160,260.00 |
| Sep 30, 2023 | 32,985.00 |
| Mar 31, 2023 | 2.31 Mn |
| Mar 31, 2022 | 937,052.00 |
| Jun 30, 2021 | 3.61 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 226,299.20 |